Skip to content

Soligenix spikes ahead of ricin vaccine data presentation

April 19, 2017

Thinly traded nano cap Soligenix (SNGX +82.9%) jumps on a whopping 111x spike in volume ahead of a presentation next week on RiVax, its ricin toxin vaccine, at the 20th Annual Conference on Vaccine Research in Bethesda, MD. NY State Department of Health’s Jennifer Yates, Ph.D., will be the presenter.

In preclinical testing, RiVax, formulated with the company’s ThermoVax heat stabilization technology, demonstrated 100% protection in ricin aerosol challenge models.

The company says the data should support the FDA approval of RiVax under the “Animal Rule” which allows regulatory approval of certain drugs and biologics based on animal testing in situations where human testing is not possible or ethical.


From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: